Searched for
ONDERO
Lupin acquires two diabetes brands from Boehringer IngelheimLupin has been marketing Ondero and Ondero Met since 2015 in the Indian market as part of a co-marketing agreement with Boehringer Ingelhei...- Lupin, Boehringer Ingelheim to co-market anti-diabetes drug linagliptin in IndiaBoehringer Ingelheim will continue to sell its linagliptin under the brand names Trajenta (monotherapy) and TrajentaDuo (fixed-dose combina...
- Load More